| __timestamp | Agios Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 3243000 |
| Thursday, January 1, 2015 | 141827000 | 2472000 |
| Friday, January 1, 2016 | 220163000 | 2548000 |
| Sunday, January 1, 2017 | 292681000 | 19623000 |
| Monday, January 1, 2018 | 1397000 | 30421000 |
| Tuesday, January 1, 2019 | 1317000 | 32793999 |
| Wednesday, January 1, 2020 | 2805000 | 28304000 |
| Friday, January 1, 2021 | 18777000 | 620000 |
| Saturday, January 1, 2022 | 1704000 | 755000 |
| Sunday, January 1, 2023 | 9504000 | 1322000 |
| Monday, January 1, 2024 | 4165000 |
In pursuit of knowledge
In the dynamic world of biotechnology, understanding cost structures is crucial for investors and stakeholders. Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. offer a fascinating case study in cost of revenue trends from 2014 to 2023. Agios Pharmaceuticals experienced a significant fluctuation, with costs peaking in 2017 and then dramatically decreasing by over 95% by 2018. This volatility reflects strategic shifts and possibly changes in operational focus. In contrast, Viridian Therapeutics showed a more stable yet upward trend, with costs increasing by over 900% from 2014 to 2019, before stabilizing. This suggests a period of expansion and scaling. The data highlights the contrasting strategies of these companies in managing their cost of revenue, providing valuable insights into their operational efficiencies and market strategies.
Cost of Revenue: Key Insights for GSK plc and Viridian Therapeutics, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.
Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Incyte Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Viridian Therapeutics, Inc.
Analyzing Cost of Revenue: Sarepta Therapeutics, Inc. and Viridian Therapeutics, Inc.
Jazz Pharmaceuticals plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Veracyte, Inc. and Viridian Therapeutics, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Geron Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Iovance Biotherapeutics, Inc. vs Viridian Therapeutics, Inc.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.